Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Applied DNA Sciences Inc
APDN
Healthcare
Medical Instruments & Supplies
Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services...
segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:APDN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
Next
(7)
•••
turner20001
X
Post by
turner20001
on Jan 29, 2024 8:02pm
525 FACTUAL Reasons to SELL this DUMPSTER Stock!
525 FACTUAL Reasons to SELL this DUMPSTER Stock! 521. “We continue to expect meaningful cotton orders to arrive in the June and September quarters.” 522. “We note that the June and September quarters
...more
(7)
•••
turner20001
X
Post by
turner20001
on Jan 29, 2024 7:57pm
520 FACTUAL Reasons to SELL this DUMPSTER Stock!
520 FACTUAL Reasons to SELL this DUMPSTER Stock! 511. Here are the Details: “APDN partners with synthetic fiber producer Palmetto to expand into the synthetic fiber market.” 512. “We believe Palmetto
...more
(7)
•••
turner20001
X
Post by
turner20001
on Jan 29, 2024 7:46pm
510 FACTUAL Reasons to SELL this DUMPSTER Stock!
510 FACTUAL Reasons to SELL this DUMPSTER Stock! 501. Around June 2016, Maxim Group put out a BUY recommendation for APDN. 502. History shows that was a terrible mistake and should serve as a strong
...more
(7)
•••
turner20001
X
Post by
turner20001
on Jan 24, 2024 5:51pm
500 FACTUAL Reasons to SELL this DUMPSTER Stock!
500 FACTUAL Reasons to SELL this DUMPSTER Stock! 491. Without getting too technical, as Dr. Hayward said in the WSJ video, you can figure out where something is grown by doing an isotopic analysis of
...more
(7)
•••
turner20001
X
Post by
turner20001
on Jan 24, 2024 5:51pm
500 FACTUAL Reasons to SELL this DUMPSTER Stock!
500 FACTUAL Reasons to SELL this DUMPSTER Stock! 481. APDN’s technology is plagued with many problems. Don’t ever expect Hayward to disclose this! 482. Dimers are short DNA fragments that are used as
...more
(7)
•••
turner20001
X
Post by
turner20001
on Jan 24, 2024 5:50pm
500 FACTUAL Reasons to SELL this DUMPSTER Stock!
500 FACTUAL Reasons to SELL this DUMPSTER Stock! 471. There are many companies today whose DNA technology is vastly superior to APDN’s technology. 472. One of them manufactures a new type of synthetic
...more
(7)
•••
turner20001
X
Post by
turner20001
on Jan 24, 2024 5:49pm
500 FACTUAL Reasons to SELL this DUMPSTER Stock!
500 FACTUAL Reasons to SELL this DUMPSTER Stock! 461. If APDN is not leader in PCR DNA Technology, then who is and why? 462. “At Touchlight, we are disrupting the decades-old technology of Linear DNA
...more
(7)
•••
turner20001
X
Post by
turner20001
on Jan 24, 2024 5:48pm
500 FACTUAL Reasons to SELL this DUMPSTER Stock!
500 FACTUAL Reasons to SELL this DUMPSTER Stock! 451. CEO Hayward is now involved with experimental saRNA research and mRNA Therapeutic research. 452. Clinical trials are many years away. This is
...more
(7)
•••
turner20001
X
Post by
turner20001
on Jan 20, 2024 4:33pm
Outrageous! Why does CEO get BONUS for losing money in APDN?
As Chairman, President and CEO at APPLIED DNA SCIENCES INC, James A. Hayward made $2,068,000 in total compensation. Of this total $450,000 was received as
...more
(7)
•••
turner20001
X
Post by
turner20001
on Jan 06, 2024 9:39pm
APDN Having Serious Cash Problems!!! (See Latest SEC Filing)
"On January 4, 2024, in connection with certain cost management efforts, Applied DNA Sciences, Inc. (the "Company”) entered into letter agreements with the Company’s President and Chief
...more
(7)
•••
turner20001
X
Post by
turner20001
on Dec 20, 2023 1:40pm
Hayward - Would you like to join my BOD?
Hey Hayward if you want to start a new drug company, then I want to start a new rocket company. It really doesn't matter that we both don't have a lot of money. But wait, I'm going to
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Dec 14, 2023 8:00am
New Press Release - Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology's mRNA Manufacturing Workflow
- Agreement Seeks to Leverage Linea IVT Platform to Enable Kudo Bio to Offer a Differentiated mRNA Manufacturing Capability with Mitigated dsRNA and Reduced Turnaround Times -STONY BROOK, NY and NEEDHAM, MA / ACCESSWIRE / December 14, 2023 /Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA...
read article.
(7)
•••
turner20001
X
Post by
turner20001
on Dec 07, 2023 5:20pm
ITEM 1A. RISK FACTORS 12/7/2023 Form: 10-K - Annual Report
ITEM 1A.RISK FACTORS. Summary of Risk Factors Our business is subject to numerous risks and uncertainties, discussed in more detail in the following section. These risks include, among others
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Dec 07, 2023 4:10pm
New Press Release - Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results
- Conference Call/Webcast Scheduled for Today at 4:30 PM ET -STONY BROOK, NY / ACCESSWIRE / December 7, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced consolidated financial results for its fourth quarter...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Dec 05, 2023 8:31am
New Press Release - Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023
STONY BROOK, NY / ACCESSWIRE / December 5, 2023 /Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release its fourth quarter and full year financial results 2023 ended September...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >